![William Annett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Annett
Amministratore Delegato presso
Sustained Therapeutics, Inc.
Profilo
William Annett was the founder of Corra Life Sciences, Inc., founded in 2001, where the title held was Chief Executive Officer from 2001 to 2003.
Current jobs include Chief Executive Officer at Sustained Therapeutics, Inc. since 2022, Director at California Biomedical Innovation Alliance since 2015, and Director at Imagia Canexia Health since 2022.
Former jobs include Chief Executive Officer at BioFX Laboratories, Inc., Managing Director at Accenture LLC from 2011 to 2014, Director at Insight Molecular Diagnostics, Inc. in 2015, and Principal at Lineage Cell Therapeutics, Inc. Education includes an MBA from Harvard Business School.
Posizioni attive di William Annett
| Società | Posizione | Inizio |
|---|---|---|
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Direttore/Membro del Consiglio | 23/11/2015 |
Imagia Canexia Health
 Imagia Canexia Health Packaged SoftwareTechnology Services Provides AI-based cancer genomic information solutions | Direttore/Membro del Consiglio | 22/09/2022 |
Sustained Therapeutics, Inc.
 Sustained Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Engages in production of sustained release formulations of generic drugs | Amministratore Delegato | 22/09/2022 |
Precedenti posizioni note di William Annett
| Società | Posizione | Fine |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Amministratore Delegato | 01/07/2019 |
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Provides financial and investment services | Amministratore Delegato | 01/01/2014 |
Corra Life Sciences, Inc. | Amministratore Delegato | 01/01/2003 |
| LINEAGE CELL THERAPEUTICS, INC. | Corporate Officer/Principal | - |
BioFX Laboratories, Inc.
 BioFX Laboratories, Inc. BiotechnologyHealth Technology Develops and supplies reagents for the biomedical research market | Amministratore Delegato | - |
Formazione di William Annett
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
BioFX Laboratories, Inc.
BioFX Laboratories, Inc. BiotechnologyHealth Technology Develops and supplies reagents for the biomedical research market | Health Technology |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Provides financial and investment services | Commercial Services |
Corra Life Sciences, Inc. | |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
Imagia Canexia Health
Imagia Canexia Health Packaged SoftwareTechnology Services Provides AI-based cancer genomic information solutions | Technology Services |
Sustained Therapeutics, Inc.
Sustained Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Engages in production of sustained release formulations of generic drugs | Health Technology |
